NUCLE.AI
Nucle.ai is a revolutionary network that leverages core blockchain principles and crowdsourced machine learning to learn and extrapolate insights from vast sources of medical and biological data. By joining artificial and human intelligence, Nucle.ai is guiding healthcare towards developing new and innovative solutions. It is home to collaboration between statisticians and data scientists all working toward the same goal of improving healthcare and biotechnology.
NUCLE.AI
Industry:
Artificial Intelligence Biotechnology Blockchain Health Care Information Technology Machine Learning
Founded:
2017-07-01
Status:
Active
Similar Organizations
eHOSP
eHOSP manages patient’s health history and automates healthcare services with electronic health cards, Blockchain tech and Cloud services
Finserv Experts Limited
Independent consultancy offering advisory and solution delivery services in blockchain, machine learning, and agile/devops adoption
MGH & BWH Center for Clinical Data Science
MGH & BWH Center for Clinical Data Science was founded to build a smarter healthcare system.
Neutrino Group
Neutrino Group is a multi disciplinary group having business in the field of Technology, Aviation & Aerospace, RE asset management
More informations about "Nucle.ai"
Nucle.ai - Crunchbase Company Profile & Funding
Nucle.ai is a revolutionary network that leverages blockchain principles and crowdsourced machine learning to extrapolate medical insights. Nucle.ai received backing from Merck’s …See details»
Homepage 2024 - Nucleai
At Nucleai, we bring together leading minds in pathology, medicine, biology, engineering, and artificial intelligence to tackle the most complex challenges in healthcare, with the goal of …See details»
Nucle.ai - Contacts, Employees, Board Members, Advisors & Alumni
Nucle.ai is a revolutionary network that leverages blockchain principles and crowdsourced machine learning to extrapolate medical insights.See details»
Leadership - Nucleai
Leadership Transforming Precision Medicine with AI-powered Pathology Our team’s work is a unique collaboration of experienced AI technologists, physicians and exceptional healthcare research professionals.See details»
Nucleai Company Profile 2024: Valuation, Funding & Investors
Operator of spatial biology software platform intended for precision medicine and tends to transform healthcare through artificial intelligence.See details»
Nucle.ai - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nucle.ai is a revolutionary network that leverages blockchain principles and crowdsourced machine learning to extrapolate medical insights.See details»
Nucleai - LinkedIn
Nucleai Brings AI-powered spatial biology technology to the forefront of precision medicine to improve drug development, clinical treatment decisions, and patient outcomes. Nucleai works with...See details»
Nucle.ai - Drug pipelines, Patents, Clinical trials - Synapse
Explore Nucle.ai with its drug pipeline, therapeutic area, technology platform, .See details»
Merck’s Corporate Venture M Ventures Arm Backs …
CHICAGO–(BUSINESS WIRE)–Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, has secured a $14 million …See details»
Nucle.ai - Crunchbase
Nucle.ai is a revolutionary network that leverages blockchain principles and crowdsourced machine learning to extrapolate medical insights.See details»
Nucleai Launches New Multiplex Imaging Spatial …
Nov 7, 2022 · Nucleai will present new data demonstrating the power of its new mIF pipeline to correlate spatial features with patient outcomes in colorectal cancer (CRC) at the Society for Immunotherapy of...See details»
Israeli Firm Nucleai Raises $33M For Its AI Pathology Platform
Mar 22, 2022 · Israeli AI-driven spatial biology company Nucleai, announced this week it has raised $33 million in a Series B funding round to further expand its spatial biology platform. …See details»
Nucleai Academy - Nucleai
How AI-driven spatial analysis can extract novel patterns from H&E, immunohistochemistry (IHC), multiplex IHC, and multiplex immunofluorescence (mIF) images. Register to join us for this …See details»
Nucle
Nucle.ai is a collection of tools for exploring latent places.See details»
Nucleai - Crunchbase Company Profile & Funding
Apr 3, 2018 · Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages …See details»
Nuclei, AI Spatial Biology Startup, Partners with US-Based Sirona DX
Jul 18, 2022 · Nucleai is developing an artificial intelligence-based precision oncology platform for research and treatment decisions. In March the company announced $33 million in a Series B …See details»
Nucleai in The News
Nucleai Highlights AI-Powered Spatial Biomarker Breakthroughs to Enhance Immunotherapy Success for Lung and Skin Cancer Patients at November 5, 2024 Top 10 Spatial Biology …See details»
Spatial AI biomarker startup Nucleai raises $14 million led by
Apr 3, 2024 · Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, announced …See details»
Careers - Nucleai
Come join Nucleai and join our team of experienced AI engineers and world renowned clinicians in our mission to unlock pathology information, develop novel precision medicine technologies …See details»
Nucleai AI-Powered Spatial Biology Platform
Nucleai’s ATOM spatial biology platform leverages computer vision and deep neural networks to structure and characterize tissue and cell architecture in cancer pathology images – helping …See details»